NewVac Presented Results of Quisinostat's Phase II Clinical Trial at ASCO 2017
SAN DIEGO, June 26, 2017 /PRNewswire/ -- NewVac, LLC today announced detailed primary results of Phase II clinical trial of quisinostat, a novel selective oral histone deacetylase (HDAC1) inh...